• 1
    Smith-Garvin, J. E., Koretzky, G. A. and Jordan, M. S., T cell activation. Annu. Rev. Immunol. 2009. 27: 591619.
  • 2
    Collins, M., Ling, V. and Carreno, B. M., The B7 family of immune-regulatory ligands. Genome Biol. 2005. 6: 223230.
  • 3
    Driessens, G., Kline, J. and Gajewski, T. F., Costimulatory and coinhibitory receptors in anti-tumor immunity. Immunol. Rev. 2009. 229: 126144.
  • 4
    Sharpe, A. H., Mechanisms of costimulation. Immunol. Rev. 2009. 229: 511.
  • 5
    Zang, X. and Allison, J. P., The B7 family and cancer therapy: costimulation and coinhibition. Clin. Cancer Res. 2007. 13: 52715279.
  • 6
    Graf, M., Reif, S., Hecht, K., Pelka-Fleischer, R., Kroell, T., Pfister, K. and Schmetzer, H., High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML). Ann. Hematol. 2005. 84: 287297.
  • 7
    Hirano, N., Takahashi, T., Takahashi, T., Ohtake, S., Hirashima, K., Emi, N., Saito, K. et al., Expression of costimulatory molecules in human leukemias. Leukemia 1996. 10: 11681176.
  • 8
    Tamura, H., Dan, K., Tamada, K., Nakamura, K., Shioi, Y., Hyodo, H., Wang, S. D. et al., Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia. Clin. Cancer Res. 2005. 11: 57085717.
  • 9
    Maeda, A., Yamamoto, K., Yamashita, K., Asagoe, K., Nohgawa, M., Kita, K., Iwasaki, H. et al., The expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7-2-positive leukaemia. Br. J. Hematol. 1998. 102: 12571262.
  • 10
    Chen, X., Liu, S., Wang, L., Zhang, W., Ji, Y. and Ma, X., Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia. Cancer Biol. Ther. 2008. 7: 624629.
  • 11
    Whiteway, A., Corbett, T., Anderson, R., Macdonald, I. and Prentice, H. G., Expression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remission. Br. J. Hematol. 2003. 120: 442451.
  • 12
    Salih, R. H., Wintterle, S., Krusch, M., Kroner, A., Huang, Y. H., Chen, L. and Wiendl, H., The role of leukemia-derived B7-H1 (PD-L1) in tumor – T-cell interactions in humans. Exp. Hematol. 2006. 34: 888894.
  • 13
    Norde, W. J., Maas, F., Hobo, W., Korman, A., Quigley, M., Kester, M. G. D., Hebeda, K. et al., PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation. Cancer Res. 2011. 71: 51115122.
  • 14
    Berthon, C., Driss, V., Liu, J., Kuranda, K., Leleu, X., Jouy, N., Hetuin, D. et al., In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol. Immunother. 2010. 59: 18391849.
  • 15
    Saudemont, A. and Quesnel, B., In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004. 104: 21242133.
  • 16
    Kaleem, Z., Crawford, E., Pathan, M. H., Jasper, L., Covinsky, M. A., Johnson, L. R. and White, G., Flow cytometric analysis of acute leukemias diagnostic utility and critical analysis of data. Arch. Pathol. Lab. Med. 2003. 127: 4248.
  • 17
    Bain, B. J., Leukemia diagnosis. Blackwell Science, Malden, 1999.
  • 18
    Birnie, G., The HL-60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer 1988. 58: 4145.
  • 19
    White, S. L., Belov, L., Barber, N., Hodgkin, P. D. and Christopherson, R. I., Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha, 25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate. Leuk. Res. 2005. 29: 11411151.
  • 20
    Dalton, W. T., Jr., Ahearn, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A. and Trujillo, J. M., HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 1988. 71: 242247.
  • 21
    Ford, G. S., Barnhart, B., Shone, S. and Covey, L. R., Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation. J. Immunol. 1999. 162: 40374044.
  • 22
    Nunes, J., Klasen, S., Franco, M. D., Lipcey, C., Mawas, C., Bagnasco, M. and Olive, D., Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity. Biochem. J. 1993. 293: 835842.
  • 23
    Kariv, I., Truneh, A. and Sweet, R. W., Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 1996. 157: 2938.
  • 24
    Botturi, K., Lacoeuille, Y., Thomas, P., Boniface, S., Reynaud-Gaubert, M. and Mangan, A., CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur. Respir. J. 2008. 31: 11671176.
  • 25
    Dunham, R., Cervasi, B., Brenchley, J., Albrecht, H., Weintrob, A., Sumpter, B., Engram, J. et al., CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection. J. Immunol. 2008. 180: 55825592.
  • 26
    Keir, M. E., Butte, M. J., Freeman, G. J. and Sharpe, A. H., PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008. 26: 677704.
  • 27
    Zitvogel, L., Tesniere, A. and Kroemer, G., Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 2006. 6: 715727.
  • 28
    Buggins, A. G. S., Lea, N., Gaken, J., Darling, D., Farzaneh, F., Mufti, G. J. and Hirst, W. J. R., Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 1999. 94: 34793490.
  • 29
    Cignetti, A., Vallario, A., Roato, I., Circosta, P., Allione, B., Casorzo, L., Ghia, P. et al., Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J. Immunol. 2004. 173: 28552865.
  • 30
    Costello, R., Mallet, F., Sainty, D., Maraninchi, D., Gastaut, J. A. and Olive, D., Regulation of CD80/B7–1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur. J. Immunol. 1998. 28: 90103.
  • 31
    Kondo, A., Yamashita, T., Tamura, H., Zhao, W., Tsuji, T., Shimizu, M., Shinya, E. et al., Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes. Blood 2010. 116: 11241131.
  • 32
    Bennett, F., Luxenberg, D., Ling, V., Wang, I. M., Marquette, K., Lowe, D., Khan, N. et al., Program Death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 2003. 170: 711718.
  • 33
    Ge, W., Ma, X., Li, X., Wang, Y., Li, C., Meng, H., Liu, X. et al., B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells. Leuk. Res. 2009. 33: 948957.
  • 34
    Vereecque, R., Buffenoir, G., Gonzalez, R., Cambier, N., Hetuin, D., Bauters, F., Fenaux, P. et al., γ-ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br. J. Hematol. 2000. 108: 825831.
  • 35
    Maeda, T., Towatari, M., Kosugi, H. and Saito, H., Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood 2000. 96: 38473856.
  • 36
    Vereecque, R., Saudemont, A. and Quesnel, B., Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells. Leukemia 2004. 18: 12231230.